“The lead story in The Washington Post’s Health section last week, on why some people seem immune to AIDS, focused in part on a top physician at Massachusetts General Hospital.
The work of researcher Bruce Walker, who runs the hospital’s Partners AIDS Research Center, was first spotlighted in the third and fourth paragraphs. The article ended with a dutiful disclosure that it was condensed from one that had run in Proto, the magazine of, yes, Massachusetts General Hospital.
What gives? Health Editor Frances Stead Sellers, who obtained the piece without charge, says Proto is “one of the best biomedical magazines,” that the article was by an established freelancer and that she was transparent about the story’s origin. “The cure for a perceived conflict is disclosure. . . . I felt with this piece I was bringing something very interesting to readers,” she says.
The magazine is produced by Time Inc. Content Solutions, where spokeswoman Carrie Jones says the hospital gets to review all copy and “to bask in the reflected glory” of a high-quality publication.
Sellers, who had run an earlier piece from Proto, says early-retirement buyouts at The Post have cut the weekly section’s full-time staff from four to none, forcing her to rely heavily on freelancers. “If I had a whole bundle of reporters, I wouldn’t be thinking of doing this,” she says. “
Opinions on other issues in news, journals, PR, advertising, marketing
A lot of interesting workshops are happening now at the #NBCCSummit! @garyschwitzer, the publisher of @HealthNewsRevu, is discussing new cancer research news. #BeBold
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like